iuvo BioScience Hires Dr. Christopher Houston as Director, Analytical Chemistry
November 10, 2015
iuvo BioScience is pleased to announce the hiring of Dr. Christopher Houston, Ph.D. as Director, Analytical Chemistry. Dr. Houston was most recently employed at Bausch & Lomb as a Senior Principle Scientist, specializing in structure elucidation with an emphasis on extractable / leachable chemsitry. Please click here to read the press release and learn more about Chris.
Bob Duffy (President & CEO, Rochester Business Alliance) visits iuvo BioScience
August 10, 2015
Today, Bob Duffy (President & CEO, Rochester Business Alliance) visited iuvo BioScience to get to know us a bit better, understand our service offerings, speak with our employees and explore ways the RBA can help us achieve our goals and achieve our Mission of helping bring life-enhancing therapies to patients and consumers. Bob left with a better understanding of our business, and we look forward to furthering our partnership with with the RBA. The link to the RBA Twitter page shows photos of the visit.
Tartan Holdings, LLC Acquires Real Estate and Assets from Moog Inc. – Launches iuvo BioScience
Rochester, NY – On Friday, March 27, 2015, Tartan Holdings, LLC (Rochester, NY) purchased real estate and assets from Moog Inc. (East Aurora, NY). The real estate and assets from MMC Sterilization (Erie, PA) and Moog Medical Devices Rochester (Rush, NY) have been acquired by Tartan Holdings, LLC for an undisclosed sum. In conjunction with this acquisition, Tartan Holdings, LLC has launched a new company, iuvo BioScience.